HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies
HIV-1 latency remains a barrier to a functional cure because of the ability of virtually silent yet inducible proviruses within reservoir cells to transcriptionally reactivate upon cell stimulation. HIV-1 reactivation occurs through the sequential action of host transcription factors (TFs) during th...
Main Authors: | Usman Hyder, Ashutosh Shukla, Ashwini Challa, Iván D’Orso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/2/287 |
Similar Items
-
Multiplexed <i>tat</i>-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape
by: Youdiil Ophinni, et al.
Published: (2020-10-01) -
Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription
by: Michaela A. Fisher, et al.
Published: (2024-03-01) -
Comparison of CRISPR–Cas9 Tools for Transcriptional Repression and Gene Disruption in the BEVS
by: Mark R. Bruder, et al.
Published: (2021-09-01) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01) -
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)